Last Updated: 16 Sep 2024
Executive Summary
Welltower Inc. (WELL) is a real estate investment trust (REIT) that invests in healthcare infrastructure. The company has a market capitalization of $79.04 billion and a dividend yield of 0.0207%. WELL's stock price is currently trading at $129.75, below its 52-week high of $129.87. Analysts have a strong buy rating on the stock, with an average target price of $122.18.
Company Overview
Welltower Inc. was founded in 1970 and is headquartered in Toledo, Ohio. The company invests in a portfolio of healthcare properties, including senior housing, skilled nursing facilities, and medical office buildings. WELL has a presence in the United States, Canada, and the United Kingdom.
Fundamental Analysis
WELL's financial performance has been strong in recent years. The company's revenue and earnings have grown steadily, and its profit margin has improved. WELL's return on assets and return on equity are also healthy.
The company's key financial metrics are as follows:
Revenue: $7.16 billion (TTM)
Net income: $1.08 billion (TTM)
EBITDA: $2.78 billion
EPS: $1.08 (TTM)
Dividend yield: 0.0207%
Technical Analysis
WELL's stock price has been trading in a range between $76.40 and $129.87 over the past 52 weeks. The stock is currently trading near the top of its range. The 50-day moving average is $115.01, and the 200-day moving average is $99.12.
The technical indicators are mixed. The relative strength index (RSI) is above 70, which indicates that the stock is overbought. However, the moving average convergence divergence (MACD) is above its signal line, which indicates that the stock is in a bullish trend.
Short Term Outlook
In the short term, WELL's stock price is likely to continue trading in a range. The stock is overbought, but the MACD is bullish. If the stock breaks out above $130, it could rally to its target price of $122.18. However, if the stock falls below $125, it could fall to its 50-day moving average of $115.01.
Long Term Outlook
In the long term, WELL's stock price is likely to continue to grow. The company's fundamentals are strong, and the demand for healthcare infrastructure is expected to increase in the coming years. WELL is well-positioned to benefit from these trends.
Analyst Recommendations
Analysts have a strong buy rating on WELL's stock. The average target price is $122.18. Four analysts recommend a strong buy, 10 recommend a buy, and five recommend a hold. No analysts recommend a sell or strong sell.
